Literature DB >> 7555510

Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.

S Nielsen1, O Schmitz, H Orskov, C E Mogensen.   

Abstract

OBJECTIVE: To investigate whether insulin resistance and microalbuminuria are associated in non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS: Insulin sensitivity was assessed using a hyperinsulinemic euglycemic clamp in 11 normoalbuminuric and 9 microalbuminuric NIDDM patients matched for sex, age, body composition, glycemic control, diabetes duration, and therapy.
RESULTS: Isotopically determined glucose disposal was similar in normo- and microalbuminuric patients in the basal state (mean +/- SD; 3.30 +/- 1.01 vs. 3.46 +/- 0.82 mg.kg lean body mass [LBM]-1.min-1; NS) and during hyperinsulinemia (7.16 +/- 2.65 vs. 6.63 +/- 2.88 mg.kg LBM-1.min-1;NS). No difference was observed in nonoxidative glucose disposal or lipid oxidation. Endogenous glucose production was equally suppressed by insulin (-0.08 +/- 0.99 vs. 0.30 +/- 1.12 mg.kg-1 LBM.min-1; NS). Glucose oxidation tended to be lower in the normoalbuminuric patients in the basal state (1.16 +/- 0.37 vs. 1.41 +/- 0.36 mg.kg LBM-1.min-1) and during hyperinsulinemia (2.35 +/- 0.72 vs. 2.90 +/- 0.77 mg.kg LBM-1.min-1; both P < 0.15). Urinary albumin excretion rate correlated with the insulin-stimulated glucose oxidation rate (r = 0.59, P = 0.0064), and a similar trend was seen in the basal state (r = 0.42, P = 0.063). Protein oxidation was higher in normoalbuminuric patients (1.6 +/- 0.5 vs. 1.0 +/- 0.4 mg.kg LBM-1.min-1; P = 0.017) and correlated inversely with albuminuria (r = -0.70, P = 0.0007). Serum growth hormone increased during insulin infusion; however, the increase was significantly greater in microalbuminuric patients. Plasma lipoproteins, maximal aerobic capacity, and 24-h ambulatory blood pressure were similar in the two groups.
CONCLUSIONS: Basal and insulin-stimulated glucose uptakes are comparable in carefully matched normo- and microalbuminuric NIDDM patients, and glucose oxidation may be positively related to albuminuria. The inverse relation between protein oxidation and albuminuria may be due to higher growth hormone levels during daily life perturbations in glucose in microalbuminuric patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555510     DOI: 10.2337/diacare.18.6.834

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome.

Authors:  S Bo; L Monge; C Macchetta; G Menato; S Pinach; B Uberti; G Pagano
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

Review 2.  Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.

Authors:  Alexandra Jauregui; Daniel H Mintz; Peter Mundel; Alessia Fornoni
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-11       Impact factor: 2.894

3.  Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic β-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes.

Authors:  Claire K Mulvey; Ann M McNeill; Cynthia J Girman; Timothy W Churchill; Karen Terembula; Jane F Ferguson; Rachana Shah; Nehal N Mehta; Atif N Qasim; Michael R Rickels; Muredach P Reilly
Journal:  Diabetes Care       Date:  2013-08-15       Impact factor: 19.112

4.  Relationships of pancreatic beta-cell function with microalbuminuria and glomerular filtration rate in middle-aged and elderly population without type 2 diabetes mellitus: a Chinese community-based analysis.

Authors:  Shihui Fu; Shanjing Zhou; Leiming Luo; Ping Ye
Journal:  Clin Interv Aging       Date:  2017-05-03       Impact factor: 4.458

5.  The association of glucose metabolism and kidney function in middle-aged adults.

Authors:  Marielle A Schroijen; Renée de Mutsert; Friedo W Dekker; Aiko P J de Vries; Eelco J P de Koning; Ton J Rabelink; Frits R Rosendaal; Olaf M Dekkers
Journal:  Clin Kidney J       Date:  2021-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.